Search This Blog

Tuesday, April 28, 2026

AstraZeneca wins FDA approval for once-weekly SAPHNELO Pen autoinjector for lupus

 


  • SAPHNELO Pen approval allows once-weekly subcutaneous self-administration for adults with systemic lupus erythematosus in the US.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)